Ipratropium bromide non-comp
Products billed under this code include Ipratropium Bromide.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ipratropium Bromide.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 00378-7970-52 | 13 | $5.785 |
| Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 00378-7970-55 | 15 | $6.675 |
| Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 00378-7970-91 | 30 | $13.35 |
| Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 00378-7970-93 | 15 | $6.675 |
| Ipratropium Bromide | Nephron SC, Inc. | 00487-9801-01 | 15 | $6.675 |
| Ipratropium Bromide | Nephron SC, Inc. | 00487-9801-25 | 13 | $5.785 |
| Ipratropium Bromide | Nephron SC, Inc. | 00487-9801-30 | 15 | $6.675 |
| Ipratropium Bromide | Nephron SC, Inc. | 00487-9801-60 | 30 | $13.35 |
| Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 47335-0706-49 | 13 | $5.785 |
| Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 47335-0706-52 | 15 | $6.675 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 47335-0706-54 | 30 | $13.35 |
| Ipratropium Bromide | A-S Medication Solutions | 50090-0668-00 | 13 | $5.785 |
| Ipratropium Bromide | A-S Medication Solutions | 50090-6373-00 | 13 | $5.785 |
| Ipratropium Bromide | American Health Packaging | 60687-0394-83 | 15 | $6.675 |
| Ipratropium Bromide | Chartwell | 62135-0830-84 | 15 | $6.675 |
| Ipratropium Bromide | Rising Pharma Holdings, Inc. | 64980-0640-02 | 13 | $5.785 |
| Ipratropium Bromide | Rising Pharma Holdings, Inc. | 64980-0640-03 | 15 | $6.675 |
| Ipratropium Bromide | Rising Pharma Holdings, Inc. | 64980-0640-06 | 30 | $13.35 |
| Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 76204-0100-01 | 15 | $6.675 |
| Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 76204-0100-25 | 13 | $5.785 |
| Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 76204-0100-30 | 15 | $6.675 |
| Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 76204-0100-60 | 30 | $13.35 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.445 | +$0.001 | 1 MG | Ipratropium bromide non-comp | v1, posted September 17, 2026 |
| 3Q26 | $0.444 | +$0.001 | 1 MG | Ipratropium bromide non-comp | v1, posted September 15, 2026 |
| 2Q26 | $0.443 | +$0.043 | 1 MG | Ipratropium bromide non-comp | v1, posted September 15, 2026 |
| 1Q26 | $0.40 | +$0.01 | 1 MG | Ipratropium bromide non-comp | v1, posted September 15, 2026 |
| 4Q25 | $0.39 | −$0.004 | 1 MG | Ipratropium bromide non-comp | v1, posted September 8, 2026 |
| 3Q25 | $0.394 | +$0.032 | 1 MG | Ipratropium bromide non-comp | v1, posted March 10, 2026 |
| 2Q25 | $0.362 | −$0.005 | 1 MG | Ipratropium bromide non-comp | v1, posted March 10, 2026 |
| 1Q25 | $0.367 | +$0.004 | 1 MG | Ipratropium bromide non-comp | v1, posted December 19, 2025 |
| 4Q24 | $0.363 | −$0.012 | 1 MG | Ipratropium bromide non-comp | v1, posted June 11, 2025 |
| 3Q24 | $0.375 | +$0.044 | 1 MG | Ipratropium bromide non-comp | v1, posted June 11, 2025 |
| 2Q24 | $0.331 | +$0.008 | 1 MG | Ipratropium bromide non-comp | v1, posted March 11, 2025 |
| 1Q24 | $0.323 | +$0.005 | 1 MG | Ipratropium bromide non-comp | v1, posted December 19, 2024 |
| 4Q23 | $0.318 | +$0.06 | 1 MG | Ipratropium bromide non-comp | v1, posted October 10, 2024 |
| 3Q23 | $0.258 | +$0.023 | 1 MG | Ipratropium bromide non-comp | v1, posted June 5, 2024 |
| 2Q23 | $0.235 | +$0.009 | 1 MG | Ipratropium bromide non-comp | v1, posted February 23, 2024 |
| 1Q23 | $0.226 | +$0.012 | 1 MG | Ipratropium bromide non-comp | v1, posted December 6, 2023 |
| 4Q22 | $0.214 | +$0.014 | 1 MG | Ipratropium bromide non-comp | v1, posted June 22, 2023 |
| 3Q22 | $0.20 | +$0.004 | 1 MG | Ipratropium bromide non-comp | v1, posted June 9, 2023 |
| 2Q22 | $0.196 | −$0.007 | 1 MG | Ipratropium bromide non-comp | v1, posted December 14, 2022 |
| 1Q22 | $0.203 | +$0.005 | 1 MG | Ipratropium bromide non-comp | v1, posted June 8, 2022 |
| 4Q21 | $0.198 | −$0.001 | 1 MG | Ipratropium bromide non-comp | v1, posted June 2, 2022 |
| 3Q21 | $0.199 | −$0.005 | 1 MG | Ipratropium bromide non-comp | v1, posted June 2, 2022 |
| 2Q21 | $0.204 | +$0.002 | 1 MG | Ipratropium bromide non-comp | v1, posted March 1, 2022 |
| 1Q21 | $0.202 | – | 1 MG | Ipratropium bromide non-comp | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.